General Information of Drug (ID: DM01RZX)

Drug Name
QNZ 46 Drug Info
Synonyms KB-275239
Indication
Disease Entry ICD 11 Status REF
Discovery agent N.A. Investigative [1]
Cross-matching ID
PubChem CID
76850154
TTD Drug ID
DM01RZX

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Discontinued Drug(s)
Investigative Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
L-689560 DMCVY4U Neurodegenerative disorder 8A20-8A23 Terminated [2]
D-aspartic acid DM7Z892 Discovery agent N.A. Investigative [2]
[3H]CPP DMR5UBF Discovery agent N.A. Investigative [2]
2-Methylamino-succinic acid(NMDA) DMKP6BM Discovery agent N.A. Investigative [2]
[3H]MDL105519 DMPKGHB Discovery agent N.A. Investigative [2]
[3H]CGP39653 DMITR7A Discovery agent N.A. Investigative [2]
homoquinolinic acid DMBW5DU Discovery agent N.A. Investigative [2]
[3H]dizocilpine DMEC2PF Discovery agent N.A. Investigative [2]
CGP61594 DM8KFZH Discovery agent N.A. Investigative [2]
(RS)-(tetrazol-5-yl)glycine DMYZCRF Discovery agent N.A. Investigative [2]
⏷ Show the Full List of 10 Drug(s)

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Glutamate receptor ionotropic NMDA 2D (GluN2D) TT5POTG NMDE4_HUMAN Modulator (allosteric modulator) [1]

References

1 Structural and mechanistic determinants of a novel site for noncompetitive inhibition of GluN2D-containing NMDA receptors. J Neurosci. 2011 Mar 9;31(10):3650-61.
2 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Target id: 459).